Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001209191-21-064588

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 41,638 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jacobson Mark L. CHIEF OPERATING OFFICER 2021-11-12 Grant or award · Employee Stock Option (Right to Buy) +41,638 41,638 D
Loading xslF345X03/doc4.xml…